HOME
RESOURCES
MEMBERS
EVENTS
PATIENTS
NEWS
ABOUT
Overview
Quality Initiatives
Join
Health Equity
Team
Contact Us
Event Recordings
Publications
Patient Data Dashboard
SPECIALTY CARE
Nephrology
Endocrinology
MY RESOURCES
Point of Care Tools
My Bookmarks
Coverage Checker
ADMIN PORTAL
PATIENT DATA DASHBOARD
NEWS

ABOUT

OverviewQuality InitiativesJoinHealth EquityTeamContact UsEvent RecordingsPublicationsPatient Data Dashboard

SPECIALTY CARE

NephrologyEndocrinology

MY RESOURCES

Point of Care ToolsMy BookmarksCoverage Checker
ADMIN PORTAL
PATIENT DATA DASHBOARD
MCT2D Logo
RESOURCESMEMBERSEVENTSPATIENTS
Search Icon

Updated Dosing Guide for Incretin Mimetics and SGLT2 Inhibitors

February 3, 2025

MCT2D Newsletter

Subscribe to the MCT2D Newsletter

Once per month we deliver news, updates, events, and more directly to you!

ccteam@mct2d.org

ResourcesPoint of CareMy BookmarksMembersEventsNewsPatientsSpecialty CareNephrology
AboutOverviewQuality InitiativesJoinHealth EquityTeam
A nonprofit and independent licensee of the Blue Cross Blue Shield Association

Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.

Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.